- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Whether you need to manage a post-transplant infection or reduce the possibility of infection, you will find effective guidance in this handbook. The work of the American Society of Transplantation Infectious Diseases Community of Practice, this reference exclusively uses tables and flowcharts to speed up decision making.
This distinguished group of investigators and teachers provide point of care information on optimum management of infection in adult and pediatric organ and stem cell transplant patients. The unique tables and flowcharts are devised by the authors, backed up with extensive…mehr
Andere Kunden interessierten sich auch für
- Lisa NorrisTransplant Administration220,99 €
- Medical Care of the Liver Transplant Patient226,99 €
- Handbook of Renal and Pancreatic Transplantation90,99 €
- Abdominal Organ Retrieval and Transplantation Bench Surgery203,99 €
- Immunotherapy in Transplantation326,99 €
- Textbook of Transplantation and Mechanical Support for End-Stage Heart and Lung Disease, 2 Volume Set436,99 €
- Menna ClatworthyTransplantation at a Glance50,99 €
-
-
-
Whether you need to manage a post-transplant infection or reduce the possibility of infection, you will find effective guidance in this handbook. The work of the American Society of Transplantation Infectious Diseases Community of Practice, this reference exclusively uses tables and flowcharts to speed up decision making.
This distinguished group of investigators and teachers provide point of care information on optimum management of infection in adult and pediatric organ and stem cell transplant patients. The unique tables and flowcharts are devised by the authors, backed up with extensive references, making the book a fully researched yet easy to use guide.
The fast growing specialty of transplantation will be well served by this book as increasing numbers of successful procedures mean transplant teams have to be ever more alert to the possibility of and need for action in the event of ensuing infection.
This distinguished group of investigators and teachers provide point of care information on optimum management of infection in adult and pediatric organ and stem cell transplant patients. The unique tables and flowcharts are devised by the authors, backed up with extensive references, making the book a fully researched yet easy to use guide.
The fast growing specialty of transplantation will be well served by this book as increasing numbers of successful procedures mean transplant teams have to be ever more alert to the possibility of and need for action in the event of ensuing infection.
Produktdetails
- Produktdetails
- Verlag: Wiley & Sons
- 2. Aufl.
- Seitenzahl: 192
- Erscheinungstermin: 20. Juni 2011
- Englisch
- Abmessung: 246mm x 189mm x 10mm
- Gewicht: 376g
- ISBN-13: 9780470658277
- ISBN-10: 0470658274
- Artikelnr.: 32833704
- Verlag: Wiley & Sons
- 2. Aufl.
- Seitenzahl: 192
- Erscheinungstermin: 20. Juni 2011
- Englisch
- Abmessung: 246mm x 189mm x 10mm
- Gewicht: 376g
- ISBN-13: 9780470658277
- ISBN-10: 0470658274
- Artikelnr.: 32833704
Deepali Kumar, MD, MSc, FRCPC, University of Alberta, Canada Atul Humar, MD, MSc, FRCPC, University of Alberta, Canada
Part 1 General Issues and Infectious Syndromes. 1 Timeline of Infections
After Organ Transplant (Christian van Delden). 2 Timeline of Infections
After Hematopoietic Stem Cell Transplant (Sarah P. Hammond & Francisco M.
Marty). 3 Immune Reconstitution After Myeloablative Stem Cell Transplant
(Sarah P. Hammond & Francisco M. Marty). 4 Pre-transplant Infectious
Disease Evaluation of the Organ Transplant Candidate (Staci A. Fischer). 5
Pre-transplant Infectious Disease Evaluation of the Hematopoietic Stem Cell
Transplant Candidate (Staci A. Fischer). 6 Technical Complications after
Organ Transplant and Associated Infections (Abhinav Humar). 7 Evaluation
and Initial Treatment of Infectious Complications Among Organ Transplant
Recipients (Kathleen Julian). 8 Management of Infections in Kidney
Transplant Recipients (Bartholomew Bono). 9 Management of Infections in
Pancreas Transplant Recipients (Bartholomew Bono). 10 Management of
Infections in Liver Transplant Recipients (Bartholomew Bono). 11 Management
of Infections in Lung, Heart-Lung, and Heart Transplant Recipients (Shahid
Husain & S.M. Hosseini-Mogaddham). 12 Management of Infections in
Intestinal Transplant Recipients (Michael Green). 13 Antimicrobial
Management of Patients with Fever and Neutropenia Following Hematopoietic
Stem Cell Transplantation (Upton D. Allen). Part II Specific Pathogens. 14
Cytomegalovirus (Raymund R. Razonable & Atul Humar). 15 Epstein-Barr Virus
and Post-transplant Lymphoproliferative Disorders (Rebecca Madan & Betsy
Herold). 16 Management of herpes simplex virus (Marian G. Michaels). 17
Management of Varicella Zoster Virus (Marian G. Michaels). 18 Prevention
and Treatment of Human Herpesvirus 6, 7 and 8 Infections in Transplant
Recipients (Raymund R. Razonable). 19 BK Polyomavirus and
Polyomavirus-associated Nephropathy (Hans H. Hirsch). 20 Respiratory
Viruses (Oriol Manuel). 21 Human Papillomavirus (Gail E. Reid). 22
Hepatitis B (Karen E. Doucette). 23 Hepatitis C Management in Transplant
Candidates and Recipients (Karen E. Doucette). 24 Management Algorithm for
Transplantation in Patients with Human Immunodeficiency Virus (Shirish
Huprikar). 25 Management of Selected Fungal Infections After
Transplantation (Michele I. Morris). 26 Treatment of Nocardia). Infections
(Nina M. Clark). 27 Tuberculosis: Treatment and Prevention (Nina M. Clark).
28 Treatment of Non-tuberculous Mycobacterium). Infections (Nina M. Clark).
29 Pneumocystis jiroveci). Pneumonia: Prophylaxis and Therapy (Nicolas J.
Mueller). 30 Suggested Therapy of Clostridium diffi cile). Colitis After
Transplantation (Aneesh K. Mehta). 31 Diagnosis and Treatment of
Multidrug-Resistant Bacteria (Emily A. Blumberg). 32 Management of Selected
Parasitic Infections After Transplant (Sanjay Mehta & Robert Huang). Part
III Donor Issues. 33 Infectious Disease Evaluation of the Potential Organ
Donor (Staci A. Fischer). 34 Infectious Disease Evaluation of the Potential
Hematopoietic Stem Cell Transplant Donor (Staci A. Fischer). 35
Donor-derived Infections (Michael G. Ison). 36 Estimates of Window Period
Length for Serology and Nucleic Acid Testing (Atul Humar). 37 Estimates of
Residual Risk of HIV or HCV when using Selected Increased Risk Donor
Categories (Atul Humar). 38 Management of Recipients of Hepatitis B Core
Antibody-Positive Donor Organ (Karen E. Doucette). 39 Donor Tuberculosis
Issues: Potential Scenarios and Management (Camille N. Kotton & Michele I.
Morris). Part IV Prevention of Infections after Transplantation. 40
Suggested Prophylaxis Regimens in Organ Transplant Recipients (Nasia
Safdar, Germana L.M. Silva & Jennifer Hsu). 41 Antimicrobial Prophylaxis
Regimen for Allogeneic Hematopoietic Stem Cell Transplant Recipients
(Sherif Mossad). 42 Antimicrobial Prophylaxis Regimen for Autologous
Hematopoietic Stem Cell Transplant Recipients (Sherif Mossad). 43 Adult
Vaccination Schedule After Solid Organ Transplant (Marissa Wilck & Lindsey
Baden). 44 Adult Vaccination Schedule After Allogeneic Stem Cell Transplant
(Lindsey Baden & Marissa Wilck). 45 Immunizations After Pediatric Solid
Organ Transplant and Hematopoietic Stem Cell Transplant (Tanvi Sharma &
Lynne Lewis). 46 Recommendations for Travel-related Vaccinations and
Medications for Transplant Travelers (Camille N. Kotton). 47 Safe Living
Strategies for Transplant Patients (Julia Garcia-Diaz & Shannon Bergeron).
Part V Post-transplant Medications and Drug Interactions. 48 Common
Immunosuppressive Drugs, Mechanisms of Action, Side-effects, and Other
Interactions (Daniel Kaul). 49 Infectious Risks Associated with
Anti-thymocyte Globulin (ATG,Thymoglobulin) (Steven D. Burdette). 50
Infectious Risks Associated with Alemtuzumab (Campath) (Steven D.
Burdette). 51 Infectious Risks Associated with IL-2R Antagonist
[Basiliximab (Simulect) and Daclizumab (Zenapax)] (Steven D. Burdette). 52
Infectious Risks Associated With Rituximab (Rituxan) (Steven D. Burdette).
53 Drug Interactions Between Antimicrobial Agents and Common
Immunosuppressive Drugs Used in Transplantation (Christian Garzoni). 54
Antiviral Agents for Adult Transplant Recipients (Valentina Stosor). 55
Antifungal Agents in Adult Transplant Recipients (Shmuel Shoham). 56
Antiviral Agents for Pediatric Transplant Recipients (Lara Danziger-Isakov,
Lizbeth Hansen & Elizabeth Neuner). 57 Antifungal Agents for Pediatric
Transplant Recipients (Lara Danziger-Isakov, Lizbeth Hansen & Elizabeth
Neuner).
After Organ Transplant (Christian van Delden). 2 Timeline of Infections
After Hematopoietic Stem Cell Transplant (Sarah P. Hammond & Francisco M.
Marty). 3 Immune Reconstitution After Myeloablative Stem Cell Transplant
(Sarah P. Hammond & Francisco M. Marty). 4 Pre-transplant Infectious
Disease Evaluation of the Organ Transplant Candidate (Staci A. Fischer). 5
Pre-transplant Infectious Disease Evaluation of the Hematopoietic Stem Cell
Transplant Candidate (Staci A. Fischer). 6 Technical Complications after
Organ Transplant and Associated Infections (Abhinav Humar). 7 Evaluation
and Initial Treatment of Infectious Complications Among Organ Transplant
Recipients (Kathleen Julian). 8 Management of Infections in Kidney
Transplant Recipients (Bartholomew Bono). 9 Management of Infections in
Pancreas Transplant Recipients (Bartholomew Bono). 10 Management of
Infections in Liver Transplant Recipients (Bartholomew Bono). 11 Management
of Infections in Lung, Heart-Lung, and Heart Transplant Recipients (Shahid
Husain & S.M. Hosseini-Mogaddham). 12 Management of Infections in
Intestinal Transplant Recipients (Michael Green). 13 Antimicrobial
Management of Patients with Fever and Neutropenia Following Hematopoietic
Stem Cell Transplantation (Upton D. Allen). Part II Specific Pathogens. 14
Cytomegalovirus (Raymund R. Razonable & Atul Humar). 15 Epstein-Barr Virus
and Post-transplant Lymphoproliferative Disorders (Rebecca Madan & Betsy
Herold). 16 Management of herpes simplex virus (Marian G. Michaels). 17
Management of Varicella Zoster Virus (Marian G. Michaels). 18 Prevention
and Treatment of Human Herpesvirus 6, 7 and 8 Infections in Transplant
Recipients (Raymund R. Razonable). 19 BK Polyomavirus and
Polyomavirus-associated Nephropathy (Hans H. Hirsch). 20 Respiratory
Viruses (Oriol Manuel). 21 Human Papillomavirus (Gail E. Reid). 22
Hepatitis B (Karen E. Doucette). 23 Hepatitis C Management in Transplant
Candidates and Recipients (Karen E. Doucette). 24 Management Algorithm for
Transplantation in Patients with Human Immunodeficiency Virus (Shirish
Huprikar). 25 Management of Selected Fungal Infections After
Transplantation (Michele I. Morris). 26 Treatment of Nocardia). Infections
(Nina M. Clark). 27 Tuberculosis: Treatment and Prevention (Nina M. Clark).
28 Treatment of Non-tuberculous Mycobacterium). Infections (Nina M. Clark).
29 Pneumocystis jiroveci). Pneumonia: Prophylaxis and Therapy (Nicolas J.
Mueller). 30 Suggested Therapy of Clostridium diffi cile). Colitis After
Transplantation (Aneesh K. Mehta). 31 Diagnosis and Treatment of
Multidrug-Resistant Bacteria (Emily A. Blumberg). 32 Management of Selected
Parasitic Infections After Transplant (Sanjay Mehta & Robert Huang). Part
III Donor Issues. 33 Infectious Disease Evaluation of the Potential Organ
Donor (Staci A. Fischer). 34 Infectious Disease Evaluation of the Potential
Hematopoietic Stem Cell Transplant Donor (Staci A. Fischer). 35
Donor-derived Infections (Michael G. Ison). 36 Estimates of Window Period
Length for Serology and Nucleic Acid Testing (Atul Humar). 37 Estimates of
Residual Risk of HIV or HCV when using Selected Increased Risk Donor
Categories (Atul Humar). 38 Management of Recipients of Hepatitis B Core
Antibody-Positive Donor Organ (Karen E. Doucette). 39 Donor Tuberculosis
Issues: Potential Scenarios and Management (Camille N. Kotton & Michele I.
Morris). Part IV Prevention of Infections after Transplantation. 40
Suggested Prophylaxis Regimens in Organ Transplant Recipients (Nasia
Safdar, Germana L.M. Silva & Jennifer Hsu). 41 Antimicrobial Prophylaxis
Regimen for Allogeneic Hematopoietic Stem Cell Transplant Recipients
(Sherif Mossad). 42 Antimicrobial Prophylaxis Regimen for Autologous
Hematopoietic Stem Cell Transplant Recipients (Sherif Mossad). 43 Adult
Vaccination Schedule After Solid Organ Transplant (Marissa Wilck & Lindsey
Baden). 44 Adult Vaccination Schedule After Allogeneic Stem Cell Transplant
(Lindsey Baden & Marissa Wilck). 45 Immunizations After Pediatric Solid
Organ Transplant and Hematopoietic Stem Cell Transplant (Tanvi Sharma &
Lynne Lewis). 46 Recommendations for Travel-related Vaccinations and
Medications for Transplant Travelers (Camille N. Kotton). 47 Safe Living
Strategies for Transplant Patients (Julia Garcia-Diaz & Shannon Bergeron).
Part V Post-transplant Medications and Drug Interactions. 48 Common
Immunosuppressive Drugs, Mechanisms of Action, Side-effects, and Other
Interactions (Daniel Kaul). 49 Infectious Risks Associated with
Anti-thymocyte Globulin (ATG,Thymoglobulin) (Steven D. Burdette). 50
Infectious Risks Associated with Alemtuzumab (Campath) (Steven D.
Burdette). 51 Infectious Risks Associated with IL-2R Antagonist
[Basiliximab (Simulect) and Daclizumab (Zenapax)] (Steven D. Burdette). 52
Infectious Risks Associated With Rituximab (Rituxan) (Steven D. Burdette).
53 Drug Interactions Between Antimicrobial Agents and Common
Immunosuppressive Drugs Used in Transplantation (Christian Garzoni). 54
Antiviral Agents for Adult Transplant Recipients (Valentina Stosor). 55
Antifungal Agents in Adult Transplant Recipients (Shmuel Shoham). 56
Antiviral Agents for Pediatric Transplant Recipients (Lara Danziger-Isakov,
Lizbeth Hansen & Elizabeth Neuner). 57 Antifungal Agents for Pediatric
Transplant Recipients (Lara Danziger-Isakov, Lizbeth Hansen & Elizabeth
Neuner).
Part 1 General Issues and Infectious Syndromes. 1 Timeline of Infections
After Organ Transplant (Christian van Delden). 2 Timeline of Infections
After Hematopoietic Stem Cell Transplant (Sarah P. Hammond & Francisco M.
Marty). 3 Immune Reconstitution After Myeloablative Stem Cell Transplant
(Sarah P. Hammond & Francisco M. Marty). 4 Pre-transplant Infectious
Disease Evaluation of the Organ Transplant Candidate (Staci A. Fischer). 5
Pre-transplant Infectious Disease Evaluation of the Hematopoietic Stem Cell
Transplant Candidate (Staci A. Fischer). 6 Technical Complications after
Organ Transplant and Associated Infections (Abhinav Humar). 7 Evaluation
and Initial Treatment of Infectious Complications Among Organ Transplant
Recipients (Kathleen Julian). 8 Management of Infections in Kidney
Transplant Recipients (Bartholomew Bono). 9 Management of Infections in
Pancreas Transplant Recipients (Bartholomew Bono). 10 Management of
Infections in Liver Transplant Recipients (Bartholomew Bono). 11 Management
of Infections in Lung, Heart-Lung, and Heart Transplant Recipients (Shahid
Husain & S.M. Hosseini-Mogaddham). 12 Management of Infections in
Intestinal Transplant Recipients (Michael Green). 13 Antimicrobial
Management of Patients with Fever and Neutropenia Following Hematopoietic
Stem Cell Transplantation (Upton D. Allen). Part II Specific Pathogens. 14
Cytomegalovirus (Raymund R. Razonable & Atul Humar). 15 Epstein-Barr Virus
and Post-transplant Lymphoproliferative Disorders (Rebecca Madan & Betsy
Herold). 16 Management of herpes simplex virus (Marian G. Michaels). 17
Management of Varicella Zoster Virus (Marian G. Michaels). 18 Prevention
and Treatment of Human Herpesvirus 6, 7 and 8 Infections in Transplant
Recipients (Raymund R. Razonable). 19 BK Polyomavirus and
Polyomavirus-associated Nephropathy (Hans H. Hirsch). 20 Respiratory
Viruses (Oriol Manuel). 21 Human Papillomavirus (Gail E. Reid). 22
Hepatitis B (Karen E. Doucette). 23 Hepatitis C Management in Transplant
Candidates and Recipients (Karen E. Doucette). 24 Management Algorithm for
Transplantation in Patients with Human Immunodeficiency Virus (Shirish
Huprikar). 25 Management of Selected Fungal Infections After
Transplantation (Michele I. Morris). 26 Treatment of Nocardia). Infections
(Nina M. Clark). 27 Tuberculosis: Treatment and Prevention (Nina M. Clark).
28 Treatment of Non-tuberculous Mycobacterium). Infections (Nina M. Clark).
29 Pneumocystis jiroveci). Pneumonia: Prophylaxis and Therapy (Nicolas J.
Mueller). 30 Suggested Therapy of Clostridium diffi cile). Colitis After
Transplantation (Aneesh K. Mehta). 31 Diagnosis and Treatment of
Multidrug-Resistant Bacteria (Emily A. Blumberg). 32 Management of Selected
Parasitic Infections After Transplant (Sanjay Mehta & Robert Huang). Part
III Donor Issues. 33 Infectious Disease Evaluation of the Potential Organ
Donor (Staci A. Fischer). 34 Infectious Disease Evaluation of the Potential
Hematopoietic Stem Cell Transplant Donor (Staci A. Fischer). 35
Donor-derived Infections (Michael G. Ison). 36 Estimates of Window Period
Length for Serology and Nucleic Acid Testing (Atul Humar). 37 Estimates of
Residual Risk of HIV or HCV when using Selected Increased Risk Donor
Categories (Atul Humar). 38 Management of Recipients of Hepatitis B Core
Antibody-Positive Donor Organ (Karen E. Doucette). 39 Donor Tuberculosis
Issues: Potential Scenarios and Management (Camille N. Kotton & Michele I.
Morris). Part IV Prevention of Infections after Transplantation. 40
Suggested Prophylaxis Regimens in Organ Transplant Recipients (Nasia
Safdar, Germana L.M. Silva & Jennifer Hsu). 41 Antimicrobial Prophylaxis
Regimen for Allogeneic Hematopoietic Stem Cell Transplant Recipients
(Sherif Mossad). 42 Antimicrobial Prophylaxis Regimen for Autologous
Hematopoietic Stem Cell Transplant Recipients (Sherif Mossad). 43 Adult
Vaccination Schedule After Solid Organ Transplant (Marissa Wilck & Lindsey
Baden). 44 Adult Vaccination Schedule After Allogeneic Stem Cell Transplant
(Lindsey Baden & Marissa Wilck). 45 Immunizations After Pediatric Solid
Organ Transplant and Hematopoietic Stem Cell Transplant (Tanvi Sharma &
Lynne Lewis). 46 Recommendations for Travel-related Vaccinations and
Medications for Transplant Travelers (Camille N. Kotton). 47 Safe Living
Strategies for Transplant Patients (Julia Garcia-Diaz & Shannon Bergeron).
Part V Post-transplant Medications and Drug Interactions. 48 Common
Immunosuppressive Drugs, Mechanisms of Action, Side-effects, and Other
Interactions (Daniel Kaul). 49 Infectious Risks Associated with
Anti-thymocyte Globulin (ATG,Thymoglobulin) (Steven D. Burdette). 50
Infectious Risks Associated with Alemtuzumab (Campath) (Steven D.
Burdette). 51 Infectious Risks Associated with IL-2R Antagonist
[Basiliximab (Simulect) and Daclizumab (Zenapax)] (Steven D. Burdette). 52
Infectious Risks Associated With Rituximab (Rituxan) (Steven D. Burdette).
53 Drug Interactions Between Antimicrobial Agents and Common
Immunosuppressive Drugs Used in Transplantation (Christian Garzoni). 54
Antiviral Agents for Adult Transplant Recipients (Valentina Stosor). 55
Antifungal Agents in Adult Transplant Recipients (Shmuel Shoham). 56
Antiviral Agents for Pediatric Transplant Recipients (Lara Danziger-Isakov,
Lizbeth Hansen & Elizabeth Neuner). 57 Antifungal Agents for Pediatric
Transplant Recipients (Lara Danziger-Isakov, Lizbeth Hansen & Elizabeth
Neuner).
After Organ Transplant (Christian van Delden). 2 Timeline of Infections
After Hematopoietic Stem Cell Transplant (Sarah P. Hammond & Francisco M.
Marty). 3 Immune Reconstitution After Myeloablative Stem Cell Transplant
(Sarah P. Hammond & Francisco M. Marty). 4 Pre-transplant Infectious
Disease Evaluation of the Organ Transplant Candidate (Staci A. Fischer). 5
Pre-transplant Infectious Disease Evaluation of the Hematopoietic Stem Cell
Transplant Candidate (Staci A. Fischer). 6 Technical Complications after
Organ Transplant and Associated Infections (Abhinav Humar). 7 Evaluation
and Initial Treatment of Infectious Complications Among Organ Transplant
Recipients (Kathleen Julian). 8 Management of Infections in Kidney
Transplant Recipients (Bartholomew Bono). 9 Management of Infections in
Pancreas Transplant Recipients (Bartholomew Bono). 10 Management of
Infections in Liver Transplant Recipients (Bartholomew Bono). 11 Management
of Infections in Lung, Heart-Lung, and Heart Transplant Recipients (Shahid
Husain & S.M. Hosseini-Mogaddham). 12 Management of Infections in
Intestinal Transplant Recipients (Michael Green). 13 Antimicrobial
Management of Patients with Fever and Neutropenia Following Hematopoietic
Stem Cell Transplantation (Upton D. Allen). Part II Specific Pathogens. 14
Cytomegalovirus (Raymund R. Razonable & Atul Humar). 15 Epstein-Barr Virus
and Post-transplant Lymphoproliferative Disorders (Rebecca Madan & Betsy
Herold). 16 Management of herpes simplex virus (Marian G. Michaels). 17
Management of Varicella Zoster Virus (Marian G. Michaels). 18 Prevention
and Treatment of Human Herpesvirus 6, 7 and 8 Infections in Transplant
Recipients (Raymund R. Razonable). 19 BK Polyomavirus and
Polyomavirus-associated Nephropathy (Hans H. Hirsch). 20 Respiratory
Viruses (Oriol Manuel). 21 Human Papillomavirus (Gail E. Reid). 22
Hepatitis B (Karen E. Doucette). 23 Hepatitis C Management in Transplant
Candidates and Recipients (Karen E. Doucette). 24 Management Algorithm for
Transplantation in Patients with Human Immunodeficiency Virus (Shirish
Huprikar). 25 Management of Selected Fungal Infections After
Transplantation (Michele I. Morris). 26 Treatment of Nocardia). Infections
(Nina M. Clark). 27 Tuberculosis: Treatment and Prevention (Nina M. Clark).
28 Treatment of Non-tuberculous Mycobacterium). Infections (Nina M. Clark).
29 Pneumocystis jiroveci). Pneumonia: Prophylaxis and Therapy (Nicolas J.
Mueller). 30 Suggested Therapy of Clostridium diffi cile). Colitis After
Transplantation (Aneesh K. Mehta). 31 Diagnosis and Treatment of
Multidrug-Resistant Bacteria (Emily A. Blumberg). 32 Management of Selected
Parasitic Infections After Transplant (Sanjay Mehta & Robert Huang). Part
III Donor Issues. 33 Infectious Disease Evaluation of the Potential Organ
Donor (Staci A. Fischer). 34 Infectious Disease Evaluation of the Potential
Hematopoietic Stem Cell Transplant Donor (Staci A. Fischer). 35
Donor-derived Infections (Michael G. Ison). 36 Estimates of Window Period
Length for Serology and Nucleic Acid Testing (Atul Humar). 37 Estimates of
Residual Risk of HIV or HCV when using Selected Increased Risk Donor
Categories (Atul Humar). 38 Management of Recipients of Hepatitis B Core
Antibody-Positive Donor Organ (Karen E. Doucette). 39 Donor Tuberculosis
Issues: Potential Scenarios and Management (Camille N. Kotton & Michele I.
Morris). Part IV Prevention of Infections after Transplantation. 40
Suggested Prophylaxis Regimens in Organ Transplant Recipients (Nasia
Safdar, Germana L.M. Silva & Jennifer Hsu). 41 Antimicrobial Prophylaxis
Regimen for Allogeneic Hematopoietic Stem Cell Transplant Recipients
(Sherif Mossad). 42 Antimicrobial Prophylaxis Regimen for Autologous
Hematopoietic Stem Cell Transplant Recipients (Sherif Mossad). 43 Adult
Vaccination Schedule After Solid Organ Transplant (Marissa Wilck & Lindsey
Baden). 44 Adult Vaccination Schedule After Allogeneic Stem Cell Transplant
(Lindsey Baden & Marissa Wilck). 45 Immunizations After Pediatric Solid
Organ Transplant and Hematopoietic Stem Cell Transplant (Tanvi Sharma &
Lynne Lewis). 46 Recommendations for Travel-related Vaccinations and
Medications for Transplant Travelers (Camille N. Kotton). 47 Safe Living
Strategies for Transplant Patients (Julia Garcia-Diaz & Shannon Bergeron).
Part V Post-transplant Medications and Drug Interactions. 48 Common
Immunosuppressive Drugs, Mechanisms of Action, Side-effects, and Other
Interactions (Daniel Kaul). 49 Infectious Risks Associated with
Anti-thymocyte Globulin (ATG,Thymoglobulin) (Steven D. Burdette). 50
Infectious Risks Associated with Alemtuzumab (Campath) (Steven D.
Burdette). 51 Infectious Risks Associated with IL-2R Antagonist
[Basiliximab (Simulect) and Daclizumab (Zenapax)] (Steven D. Burdette). 52
Infectious Risks Associated With Rituximab (Rituxan) (Steven D. Burdette).
53 Drug Interactions Between Antimicrobial Agents and Common
Immunosuppressive Drugs Used in Transplantation (Christian Garzoni). 54
Antiviral Agents for Adult Transplant Recipients (Valentina Stosor). 55
Antifungal Agents in Adult Transplant Recipients (Shmuel Shoham). 56
Antiviral Agents for Pediatric Transplant Recipients (Lara Danziger-Isakov,
Lizbeth Hansen & Elizabeth Neuner). 57 Antifungal Agents for Pediatric
Transplant Recipients (Lara Danziger-Isakov, Lizbeth Hansen & Elizabeth
Neuner).